JP Morgan Chase
MANE

JP Morgan Chase’s Veradermics Inc MANE Stock Holding History

JP Morgan Chase’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144M Buy
1,165,584
+189,418
+19% +$17.7M 0.01% 894
2026
Q1 		$59.4M Buy
+976,166
New +$49.2M ﹤0.01% 1276

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase's MANE Position: Q2 2026 in Review

JP Morgan Chase increased its Veradermics Inc (MANE) stake by 19% in Q2 2026, buying an estimated $17.7M and bringing the position to 1,165,584 shares worth $144M. The position accounts for 0.01% of the portfolio, ranked #894.

JP Morgan Chase first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • JP Morgan Chase held 1,165,584 shares of Veradermics Inc worth $144M as of Q2 2026.
  • JP Morgan Chase bought 189,418 Veradermics Inc shares in Q2 2026, an estimated $17.7M.
  • Veradermics Inc made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #894 holding.
  • JP Morgan Chase first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.